By Healthcare Practice Leaders | February 26, 2018

BDO’s 2018 Life Sciences Outlook

BDO’s Life Sciences practice makes four predictions for the industry in 2018, including that mainstream milestone-based reimbursements and a biotech M&A recovery are coming.


By Healthcare Practice Leaders | February 12, 2018

3 Foundational Shifts in Healthcare

Three foundational shifts are behind major healthcare developments: mandates to choice, regulation to competition, and subsidies to actuarial soundness. Here’s what they mean for healthcare’s stakeholders.


By Healthcare Practice Leaders | February 05, 2018

Infographic: Looking Back at 2017 PE Healthcare Buyouts

The number of completed U.S. healthcare deals involving a private equity buyer or seller was down in 2017 compared to the previous year, but deal value saw an increase. BDO’s PErspective in Healthcare infographic has more.


By Healthcare Practice Leaders | January 29, 2018

What Life Sciences Companies Need to Know About Tax Reform

To help organizations navigate the issues most impactful and urgent to the life sciences industry, we’ve prepared a summary of the industry implications based on the signed legislation.


By Healthcare Practice Leaders | January 10, 2018

Consumers, Healthcare Orgs Unaligned on Value-Based Drug Pricing: BDO/NEJM Catalyst Survey

When it comes to aligning care outcomes with pricing, consumers and healthcare providers are, well, unaligned, a new survey from BDO and the NEJM Catalyst reveals.


By Healthcare Practice Leaders | December 01, 2017

Healthcare is Ripe for Investment—and Risk: Fall BDO Knows Healthcare Newsletter

Our Fall 2017 BDO Knows Healthcare Newsletter takes the healthcare industry’s pulse with features on the Food and Drug Administration’s (FDA) new Software PreCert Pilot Program, what providers and investors need to know when it comes to cyber risk and more.


By Healthcare Practice Leaders | November 27, 2017

Pharma Supply Chains: Steady or Susceptible? BDO Life Sciences RiskFactor Report

It’s not the risks that are unfamiliar to life sciences companies causing consternation—it’s the changes to the operating environment. With regulatory tailwinds promising to boost innovation, and pricing and value-based care considerations abounding, BDO’s Life Sciences...


By Healthcare Practice Leaders | November 17, 2017

Vlog: 3 Cybersecurity Truths Healthcare Orgs Need to Know

Watch: BDO Global lays out what organizations need to know to defend against cyberattacks. We outline three truths healthcare organizations need to know about their unique threat profile.


By Rachel Laureno | November 06, 2017

5 Indicators of Where Healthcare is Headed: As Seen from Inside the Beltway

At the Washington Business Journal’s recent Hospital CEO Summit in Washington, four healthcare leaders from Sibley Memorial Hospital, Kaiser Permanente of the Mid-Atlantic States, Children’s National Health System and George Washington University Hospital offered their insight...


By Healthcare Practice Leaders | October 30, 2017

Taking the Temperature of Healthcare M&A Activity

Despite 21 megadeals, healthcare M&A levels declined slightly in the first half of 2017. Still, there’s reason for optimism ahead as strategic and private equity buyers alike are in a strong position to move in attractive sectors. Read on for 1H 2017 healthcare and life...